SE0001440D0 - A drug against climacteric disorders - Google Patents

A drug against climacteric disorders

Info

Publication number
SE0001440D0
SE0001440D0 SE0001440A SE0001440A SE0001440D0 SE 0001440 D0 SE0001440 D0 SE 0001440D0 SE 0001440 A SE0001440 A SE 0001440A SE 0001440 A SE0001440 A SE 0001440A SE 0001440 D0 SE0001440 D0 SE 0001440D0
Authority
SE
Sweden
Prior art keywords
climacteric disorders
drug against
against climacteric
disorders
relates
Prior art date
Application number
SE0001440A
Other languages
English (en)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Original Assignee
Entretech Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entretech Medical Ab filed Critical Entretech Medical Ab
Priority to SE0001440A priority Critical patent/SE0001440D0/sv
Publication of SE0001440D0 publication Critical patent/SE0001440D0/sv
Priority to ES01922220T priority patent/ES2302728T3/es
Priority to US10/258,013 priority patent/US20040029787A1/en
Priority to EP01922220A priority patent/EP1406649B9/en
Priority to AU2001248994A priority patent/AU2001248994A1/en
Priority to PCT/SE2001/000854 priority patent/WO2001078758A1/en
Priority to DE60133050T priority patent/DE60133050T2/de
Priority to AT01922220T priority patent/ATE387213T1/de
Priority to US11/345,218 priority patent/US7727959B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
SE0001440A 2000-04-18 2000-04-18 A drug against climacteric disorders SE0001440D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0001440A SE0001440D0 (sv) 2000-04-18 2000-04-18 A drug against climacteric disorders
ES01922220T ES2302728T3 (es) 2000-04-18 2001-04-18 Uso de sustancias con actividad oxitocina contra trastornos climatericos.
US10/258,013 US20040029787A1 (en) 2000-04-18 2001-04-18 Use of substances with oxytocin activity against climacteric disorders
EP01922220A EP1406649B9 (en) 2000-04-18 2001-04-18 Use of substances with oxytocin activity against climacteric disorders
AU2001248994A AU2001248994A1 (en) 2000-04-18 2001-04-18 Use of substances with oxytocin activity against climacteric disorders
PCT/SE2001/000854 WO2001078758A1 (en) 2000-04-18 2001-04-18 Use of substances with oxytocin activity against climacteric disorders
DE60133050T DE60133050T2 (de) 2000-04-18 2001-04-18 Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden
AT01922220T ATE387213T1 (de) 2000-04-18 2001-04-18 Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden
US11/345,218 US7727959B2 (en) 2000-04-18 2006-02-02 Use of substances with oxytocin activity against climacteric disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001440A SE0001440D0 (sv) 2000-04-18 2000-04-18 A drug against climacteric disorders

Publications (1)

Publication Number Publication Date
SE0001440D0 true SE0001440D0 (sv) 2000-04-18

Family

ID=20279369

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001440A SE0001440D0 (sv) 2000-04-18 2000-04-18 A drug against climacteric disorders

Country Status (8)

Country Link
US (2) US20040029787A1 (sv)
EP (1) EP1406649B9 (sv)
AT (1) ATE387213T1 (sv)
AU (1) AU2001248994A1 (sv)
DE (1) DE60133050T2 (sv)
ES (1) ES2302728T3 (sv)
SE (1) SE0001440D0 (sv)
WO (1) WO2001078758A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2641959C (en) 2006-02-10 2016-12-20 Ferring B.V. Novel compounds
WO2009037586A2 (en) 2007-08-14 2009-03-26 Ferring B.V. Use of peptidic vasopressin receptor agonists
JP2010538989A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Ｈｂｖ感染等の治療における治療剤としてのｎｆ−カッパーｂインヒビターｓｎ５０の使用、及び必要に応じたアンギオテンシンｉｉｉの使用
WO2009033820A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009046826A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of a cyclic penta-peptide as a therapeutic agent
ATE522225T1 (de) * 2007-09-11 2011-09-15 Mondobiotech Lab Ag Verwendung des peptids phpfhlfvy (renin- inhibitor) in anti-angiogenischer therapie von gewissen erkrankungen
RU2010114024A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение гонадорелина в качестве терапевтического средства
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
EP2908840A1 (en) * 2012-10-12 2015-08-26 Peptonic Medical AB Novel use of a composition comprising oxytocin
SE1750680A1 (en) 2017-05-30 2018-12-01 Peptonic Medical Ab Composition for treating or preventing climacteric disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889844A (en) * 1985-10-22 1989-12-26 Silvetti Sr Anthony N Fructose containing wound healing preparation
CA2110176A1 (en) * 1992-03-28 1993-10-14 Akira Yanagawa Topical preparation for healing wounds of the skin
MY117988A (en) * 1995-10-03 2004-08-30 Nor Ind Inc Cleaning compositions for oil and gas well, lines, casings, formations and equipment and methods of use
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9803272D0 (sv) * 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for cell regeneration
US6333313B1 (en) * 1998-10-29 2001-12-25 Board Of Regents, The University Of Texas System Clinical use of oxytocin alone or in combination to treat bone disorders
SE0100684D0 (sv) 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter

Also Published As

Publication number Publication date
US7727959B2 (en) 2010-06-01
ES2302728T3 (es) 2008-08-01
US20060148685A1 (en) 2006-07-06
AU2001248994A1 (en) 2001-10-30
US20040029787A1 (en) 2004-02-12
ATE387213T1 (de) 2008-03-15
WO2001078758A1 (en) 2001-10-25
DE60133050D1 (de) 2008-04-10
EP1406649B1 (en) 2008-02-27
EP1406649B9 (en) 2008-10-15
DE60133050T2 (de) 2009-02-26
EP1406649A1 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
NO20030627L (no) Hydrogel-drevet medikament doseringsform
ECSP034438A (es) Nuevos peptidos como inhibidores de ns-3-serina proteasa del virus de la hepatitis c
DK1091975T3 (da) Ny cyclosporin med forbedret aktivitetsprofil
DE60018777D1 (de) Medikamentenversorgung der sub-tenon
WO2002016402A3 (en) Apoptotic compounds
NO20025450L (no) Ny farmasöytisk sammensetning
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
IL218698A0 (en) Compounds that inhibit serine protease activity and pharmaceutical compositions containing the same
WO2004089396A3 (en) Anti-fungal peptidomimetics
SE0001440D0 (sv) A drug against climacteric disorders
EE05020B1 (et) Glburiidi ravimkoostis
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
NO20064808L (no) Orale matrixformuleringer med licarbazepin
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
NO20064783L (no) Opplosningstabeletter med licarbazepin
TR200102939T2 (tr) Farmasötik bileşikler
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
SE9803272D0 (sv) A drug for cell regeneration
DE50006420D1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
SE0102910D0 (sv) New use
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
SE0000303D0 (sv) Novel compounds